Robert J Wells
Overview
Explore the profile of Robert J Wells including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
766
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhukovsky D, Rozmus C, Robert R, Bruera E, Wells R, Cohen M
Children (Basel)
. 2021 Aug;
8(8).
PMID: 34438547
Understanding the symptom and illness experience of children with advanced cancer facilitates quality care; yet, obtaining this understanding is complicated by the child's developmental level and physical and psychological health...
2.
Murphy B, Roth M, Kolb E, Alonzo T, Gerbing R, Wells R
Pediatr Blood Cancer
. 2019 Mar;
66(8):e27700.
PMID: 30908863
Children with Down syndrome have a 150-fold increased risk of developing acute myeloid leukemia (AML) and 20-fold increased risk of developing acute lymphoblastic leukemia (ALL). Although the risk of developing...
3.
Cox C, Zhu L, Kaste S, Srivastava K, Barnes L, Nathan P, et al.
Pediatr Blood Cancer
. 2017 Dec;
65(4).
PMID: 29286560
Background: The early effects of childhood acute lymphoblastic leukemia (ALL) include decreased physical function, bone mineral density (BMD/g/cm ), and health-related quality of life (HRQL). We assessed the capacity of...
4.
Maher O, Silva J, Wu J, Liu D, Cooper L, Tarek N, et al.
Pediatr Transplant
. 2017 Feb;
21(3).
PMID: 28160352
We conducted a retrospective analysis of outcomes for children and young adults with sAML/sMDS who underwent HSCT at our institution. Thirty-two patients (median age 20 years) with sAML (n=24) and...
5.
Meany H, Seibel N, Krailo M, Villaluna D, Chen Z, Gaynon P, et al.
J Immunother
. 2015 Aug;
38(7):299-305.
PMID: 26261894
Background: B43-pokeweed antiviral protein (B43-PAP) is a high-affinity anti-CD19 immunotoxin that is capable of causing apoptotic death in B-lineage leukemic cells with a drug-resistant phenotype. B43-PAP exhibited in vivo antileukemic...
6.
Symptom profiles in children with advanced cancer: Patient, family caregiver, and oncologist ratings
Zhukovsky D, Rozmus C, Robert R, Bruera E, Wells R, Chisholm G, et al.
Cancer
. 2015 Jul;
121(22):4080-7.
PMID: 26218240
Background: Systematic symptom assessment is not routinely performed in pediatric oncology. The objectives of the current study were to characterize the symptoms of pediatric oncology outpatients and evaluate agreement between...
7.
8.
Moccia M, Wells R, Adamo M
Org Biomol Chem
. 2015 Jan;
13(7):2192-5.
PMID: 25553798
Herein, we describe a short synthesis of 3-methyl-4-nitro-5-alkylethenyl isoxazoles and their reactivity as Michael acceptors. The title compounds reacted with nitromethane under phase-transfer catalysis to provide highly enantioenriched adducts (up...
9.
Radhakrishnan K, Lee A, Harrison L, Morris E, Shen V, Gates L, et al.
Pediatr Blood Cancer
. 2014 Nov;
62(2):274-278.
PMID: 25382188
Background: Ifosfamide, carboplatin, and etoposide (ICE) in children with refractory or recurrent solid tumors and lymphomas has resulted in good overall response rates (ORR). Etoposide, a topoisomerase-II inhibitor, however, has...
10.
Ness K, Kaste S, Zhu L, Pui C, Jeha S, Nathan P, et al.
Leuk Lymphoma
. 2014 Jul;
56(4):1004-11.
PMID: 25030039
This study describes skeletal, neuromuscular and fitness impairments among 109 children (median age 10 [range 4-18] years, 65.1% male, 63.3% white) with acute lymphoblastic leukemia (ALL). Outcomes were measured 7-10...